DGAKI Award for Dr. Dennis Rußkamp

Prof. Dr. Thomas Werfel (DGAKI president), PD Dr. Simon Blank (ZAUM), Ina Neumann (Sanofi Aventis)


Dr. Dennis Russkamp from the research group Molecular and Translational Allergology of PD Dr. Simon Blank (ZAUM) received the award “Novel Immunological Therapies of Allergic diseases” of the German Society of Allergology and Clinical Immunology (DGAKI). This annual award is sponsored by Sanofi Aventis and endowed with 5000 Euros. The award ceremony took place during the German Allergy Congress in Hannover on 27th September 2018 and the award was taken over by PD Dr. Blank (Photo).  

The DGAKI award is granted for outstanding work in the field of allergology and clinical immunology. Dr. Rußkamp received the award due to his research on enhancing allergen-specific immunotherapy by the use of immunomodulatory molecules and was based on a recent publication entitled: IL -4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma (Russkamp et al., Allergy 74(8):1549-1560, 2019).

> Link to publication